The effect of polymer blends on release profiles of diclofenac sodium from matrices

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 55, Issue 3, 2003, Pages 351-355

  Samani, Soliman Mohammadi ^a,b   Montaseri, Hashem ^a   Kazemi, Abdolghani ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbopol; Diclofenac sodium; Hydrophilic polymer; Hydroxylpropyl methylcellulose; Matrices

Indexed keywords

CARBOPOL 940; DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; POLYMER; WATER;

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; KINETICS; TABLET; VELOCITY; VISCOSITY;

EID: 0038061591     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(03)00030-4     Document Type: Article

References (17)

1. Hardman J.G., Limbrid L.E. Goodman's and Gilman's The pharmacological basis of therapeutics. 9th Edition :1995;McGraw Hill, New York.
2. Fowler P.D., Shadforth M.F., Crook P.R., John V.A. Plasma and synovial fluid concentration of diclofenac sodium and its major hydroxylated metabolites during long- term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol. 25:1983;389-394.
3. Willis J.V., Kendall M.J., Jack D.B. The Influence of food on the absorption of diclofenac after single and multiple oral doses. Eur. J. Clin. Pharmacol. 19:1981;33-37.
4. Chattaraj S.C., Das S.K. Effect of formulation variable on dissolution profile of diclofenac sodium from ethyl and hydroxy propyl methylcellulose tablets. Drug Dev. Ind. Pharm. 22:1996;555-559.
5. Yang L., Fassihi R. Modulation of diclofenac release from A totally soluble controlled release drug delivery system. J. Controlled Release. 44:1997;135-140.
6. Liu C.H., Kao Y.H., Chen S.C., Sokoloski T.D., Sheu M.T. In vitro and In vivo studies of the diclofenac sodium controlled release matrix tablets. J. Pharm. Pharmacol. 47:1995;360-364.
7. Nokhodchi A., Farid D.J., Nagafi M., Adrangui M. Studies on controlled release formulation of siclofenac sodium. Drug Dev. Ind. Pharm. 23:1997;1019-1023.
8. Sheu M.T., Chou H.L., Kao C.C., Liu C.H., Sokoloski T.D. Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharm. 85:1992;57-63.
9. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose(HPMC). Adv. Drug Delivery Rev. 48:2001;139-157.
10. Siepmann J., Streubel A., Peppas N.A. Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model. Pharm. Res. 19:2002;306-314.
11. Clombo P., Bettini R., Santi P., Ascentiis A.D.E., Peppas N.A. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J. Controlled Release. 39:1996;231-237.
12. Velasco M.V., Ford J.L., Rowe P., Rajabi-Siahboomi A.R. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Controlled Release. 57:1999;75-85.
13. Colombo P., Bettini R., Santi P., Peppas N.A. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm. Sci. Technol. Today. 3:2000;198-204.
14. Tahara K., Yamamoto K., Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methycellulose 2910. J. Controlled Release. 35:1995;59-66.
15. Sako K., Sawada T., Nakashima H., Yokohama S., Sonobe T. Influence of water soluble filler in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. J. Controlled Release. 81:2002;165-172.
16. Ritger P.L., Peppas N.A. Simple equation for description of solute release: part 1, Fickian and non Fickian release from nonswellable devices in the form of slab, spheres, cylinders or Disk. J. Controlled Release. 5:1987;23-36.
17. Rao Y.M., Veni J.K., Jayasagar G. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev. Ind. Pharm. 27:2001;759-766.